How the DEA’s Attempt to Reschedule Kratom Could Endanger Public Health and Addiction Treatment

When the DEA announced their sudden decision to classify kratom as a Schedule 1 substance earlier this summer, people went into an uproar. Practitioners, scientists, and even politicians threw their weight into the fight to delay the emergency rescheduling of the plant many use to treat addiction. Some of the backlash—a letter to the DEA […]

Continue Reading